MSB 3.19% 97.0¢ mesoblast limited

Cell Therapy News/Articles, page-17578

  1. 2,680 Posts.
    lightbulb Created with Sketch. 1725
    Actually it was Dr Phil Krause who said the CRL was not questioning efficacy.

    Given that this was a public statement, that has not been redacted, I can only conclude that the FDA now agrees that the cells work, albeit with potency assay issues to be addressed.


    Please educate me on why you consider the FDA agreeing on efficacy in a trial, that met it's primary endpoint. to be magic?


    Reg
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
97.0¢
Change
0.030(3.19%)
Mkt cap ! $1.107B
Open High Low Value Volume
94.0¢ 98.0¢ 92.0¢ $3.342M 3.477M

Buyers (Bids)

No. Vol. Price($)
4 33313 97.0¢
 

Sellers (Offers)

Price($) Vol. No.
97.5¢ 73982 2
View Market Depth
Last trade - 16.10pm 03/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.